Giovanni Barosi

Giovanni Barosi

UNVERIFIED PROFILE

Are you Giovanni Barosi?   Register this Author

Register author
Giovanni Barosi

Giovanni Barosi

Publications by authors named "Giovanni Barosi"

Are you Giovanni Barosi?   Register this Author

100Publications

3213Reads

6Profile Views

Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology.

Leuk Res 2019 Jun 2;81:88-94. Epub 2019 May 2.

Center for the Study of Myelofibrosis. IRCCS Policlinico S. Matteo Foundation, Pavia, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.04.016DOI Listing
June 2019

Spectrum of mutations in primary myelofibrosis: prognostic impact of the p.G646Wfs*12 mutation.

Blood 2019 Jun 10;133(26):2802-2808. Epub 2019 May 10.

Centro di Ricerca e Innovazione per le Malattie Mieloproliferative (CRIMM), Dipartimento di Medicina Sperimentale e Clinica, Azienda Ospedaliera Universitaria Careggi, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2018879536DOI Listing
June 2019

Italian expert panel consensus statement on the optimal use of PD-1 blockade therapy in classical Hodgkin lymphoma.

Leuk Lymphoma 2019 May 15;60(5):1204-1213. Epub 2018 Oct 15.

h Division of Hematology , Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan , Milan , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2018.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2018.1519808DOI Listing
May 2019

Response to the Commentary on "Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma".

Leukemia 2019 05 6;33(5):1301-1302. Epub 2019 Mar 6.

Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College, London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0432-xDOI Listing
May 2019

Is lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma?

Leukemia 2019 03 28;33(3):588-596. Epub 2019 Jan 28.

Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College, London, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41375-019-0383-2
Publisher Site
http://dx.doi.org/10.1038/s41375-019-0383-2DOI Listing
March 2019

Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera.

Leukemia 2018 09 28;32(9):2077-2081. Epub 2018 Jun 28.

Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0199-5DOI Listing
September 2018

Is there expert consensus on expert consensus?

Bone Marrow Transplant 2018 08 28;53(8):1055-1060. Epub 2018 Feb 28.

Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0128-2DOI Listing
August 2018

MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

J Clin Oncol 2018 02 9;36(4):310-318. Epub 2017 Dec 9.

Paola Guglielmelli, Giada Rotunno, Carmela Mannarelli, Annalisa Pacilli, Francesco Mannelli, and Alessandro M. Vannucchi, University of Florence, Azienda Ospedaliero Universitaria Careggi, Florence; Elisa Rumi, Vittorio Rosti, Giovanni Barosi, and Mario Cazzola, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo; Elisa Rumi and Mario Cazzola, University of Pavia, Pavia; Alessandro Rambaldi, University of Milan, Milan; Alessandro Rambaldi and Tiziano Barbui, Azienda Socio sanitaria Territoriale Papa Giovanni XXIII, Bergamo; Francesco Passamonti, University of Insubria, Varese, Italy; and Terra L. Lasho, Mythri Mudireddy, Maura Nicolosi, Animesh Pardanani, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, and Ayalew Tefferi, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.4886DOI Listing
February 2018

Endothelial-to-Mesenchymal Transition in Bone Marrow and Spleen of Primary Myelofibrosis.

Am J Pathol 2017 Aug;187(8):1879-1892

Vascular Biology Laboratory, The FIRC Institute of Molecular Oncology (IFOM) Foundation, Milan, Italy; Department of Immunology, Genetics and Pathology, University of Uppsala, Uppsala, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2017.04.006DOI Listing
August 2017

Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of Hematology.

Leuk Res 2017 07 23;58:63-72. Epub 2017 Apr 23.

Center for the Study of Myelofibrosis, Biotechnology Research Area, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico S. Matteo, Pavia, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.04.006DOI Listing
July 2017

Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.

Am J Hematol 2016 09 4;91(9):918-22. Epub 2016 Jul 4.

Department of Experimental and Clinical Medicine and DENOTHE Excellence Center, CRIMM-Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24442DOI Listing
September 2016

JAK2 exon 14 skipping in patients with primary myelofibrosis: a minor splice variant modulated by the JAK2-V617F allele burden.

PLoS One 2015 24;10(1):e0116636. Epub 2015 Jan 24.

Center for the Study and Treatment of Myelofibrosis, Biotechnology Research Laboratories, Fondazione IRCCS "Policlinico San Matteo", Pavia (PV), Italy.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0116636PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305294PMC
February 2016

Altered fibronectin expression and deposition by myeloproliferative neoplasm-derived mesenchymal stromal cells.

Br J Haematol 2016 Jan 5;172(1):140-4. Epub 2015 May 5.

Department of Molecular Medicine, University of Pavia, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13471DOI Listing
January 2016

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.

J Clin Oncol 2016 Jan 23;34(2):151-9. Epub 2015 Nov 23.

Holly Geyer, Robyn Scherber, Heidi Kosiorek, Amylou C. Dueck, and Ruben A. Mesa, Mayo Clinic, Scottsdale, AZ; Jean-Jacques Kiladjian, Hospital Saint-Louis, Paris; Francoise Boyer, Centre Hospitalier Universitaire, Angers; Gabriel Etienne, Institut Bergonie, Bordeaux; Jean-Christophe Ianotto, Centre Hospitalier Universitaire, Brest; Dana Ranta, Centre Hospitalier Universitaire, Grenoble; Lydia Roy, Centre Hospitalier Universitaire, Poitiers; Jean-Yves Cahn, Centre Hospitalier Universitaire, Grenoble, France; Zhijian Xiao, Zefeng Xu, Yue Zhang, Xiujuan Sun, Junqing Xu, and Peihong Zhang, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; Stefanie Slot and Sonja Zweegman, VU University Medical Center, Amsterdam; Peter A.W. te Boekhorst, Erasmus Medical Center, Rotterdam; Suzan Commandeur, Leiden University Medical Center, Leiden; Harry Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Frederico Sackmann, Fundaleu, Buenos Aires, Argentina; Ana Kerguelen Fuentes and Dolores Hernández-Maraver, University Hospital La Paz, Madrid; Carlos Besses, Hospital del Mar; Francisco Cervantes, University of Barcelona, Barcelona, Spain; Konstanze Döhner and Frank Stegelmann, University Hospital of Ulm; Karin Bonatz and Andreas Reiter, Universitätsmedizin Mannheim, Mannheim; Heike L. Pahl, University Hospital Freiburg, Freiburg; Martin Griesshammer, Johannes Wesling Klinikum Minden, Germany; Claire N. Harrison and Deepti Radia, Guy's and St Thomas NHS Foundation Trust; Robert Peter Gale, Imperial College, London, United Kingdom; Pablo Muxi, Hospital Británico, Montevideo, Uruguay; Peter L. Johansson and Bjorn Andreasson, NU Hospital Organization, Uddevalla; Gunnar Birgegard, University Hospital, Uppsala; Jan Samuelsson, Stockholm South Hospital, Stockholm, Sweden; Alessandro Rambaldi, Tiziano Barbui, and Maria L. Ferrari, Ospedali Riuniti di Bergamo, Bergamo; Giovanni Barosi, IRCCS Policlinico S. Matteo Foundation; Franc

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.9337DOI Listing
January 2016

Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.

Authors:
Giovanni Barosi

Curr Hematol Malig Rep 2015 Dec;10(4):362-9

Center for the Study of Myelofibrosis, Biotechnology Research Area, IRCCS Policlinico S. Matteo Foundation, Viale Golgi 19, 27100, Pavia, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs11899-015-02
Web Search
http://link.springer.com/10.1007/s11899-015-0281-2
Publisher Site
http://dx.doi.org/10.1007/s11899-015-0281-2DOI Listing
December 2015

Dysregulation of VEGF-induced proangiogenic Ca2+ oscillations in primary myelofibrosis-derived endothelial colony-forming cells.

Exp Hematol 2015 Dec 19;43(12):1019-1030.e3. Epub 2015 Oct 19.

Laboratory of General Physiology, Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2015.09.002DOI Listing
December 2015

Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper.

Clin Lymphoma Myeloma Leuk 2015 Sep 19;15(9):507-13. Epub 2015 Jun 19.

University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.06.008DOI Listing
September 2015

Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosis.

Onco Targets Ther 2015 18;8:1091-102. Epub 2015 May 18.

Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://www.dovepress.com/critical-appraisal-of-the-role-of-r
Publisher Site
http://dx.doi.org/10.2147/OTT.S31916DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445786PMC
June 2015

Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis.

Blood Cells Mol Dis 2015 Mar 15;54(3):234-41. Epub 2015 Jan 15.

Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA; Myeloproliferative Disease Research Consortium, New York, NY, USA; Department of Biomedical Sciences, Alma Mater University, Bologna, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10799796150000
Publisher Site
http://dx.doi.org/10.1016/j.bcmd.2014.12.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338409PMC
March 2015

An immune dysregulation in MPN.

Authors:
Giovanni Barosi

Curr Hematol Malig Rep 2014 Dec;9(4):331-9

Center of the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Viale Golgi 19, 27100, Pavia, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-014-0227-0DOI Listing
December 2014

Commentary.

Leuk Res 2014 Sep 11;38(9):1013-5. Epub 2014 Jul 11.

Centre for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.06.012DOI Listing
September 2014

Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter.

Authors:
Giovanni Barosi

Best Pract Res Clin Haematol 2014 Jun 18;27(2):129-40. Epub 2014 Jul 18.

Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Viale Golgi 19, 27100 Pavia, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2014.07.004DOI Listing
June 2014

CD14(bright)CD16(low) intermediate monocytes expressing Tie2 are increased in the peripheral blood of patients with primary myelofibrosis.

Exp Hematol 2014 Apr 11;42(4):244-6. Epub 2013 Dec 11.

Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2013.12.002DOI Listing
April 2014

Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups.

Haematologica 2013 Sep;98(9):1344-52

Hematology - Bone Marrow Transplantation Center, Fondazione IRCCS Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2013.084020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762089PMC
September 2013

Involvement of TGFβ1 in autocrine regulation of proplatelet formation in healthy subjects and patients with primary myelofibrosis.

Haematologica 2013 Apr 12;98(4):514-7. Epub 2013 Feb 12.

Biotechnology Laboratories, Department of Molecular Medicine, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2012.076752DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659980PMC
April 2013

SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.

Am J Hematol 2013 Mar 22;88(3):185-92. Epub 2013 Jan 22.

Istituto di Ematologia ed Oncologia Medica Seragnoli, Università di Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23372DOI Listing
March 2013

Emerging targeted therapies in myelofibrosis.

Authors:
Giovanni Barosi

Expert Rev Hematol 2012 Jun;5(3):313-24

Unit of Clinical Epidemiology and Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Viale Golgi 19, 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.12.17DOI Listing
June 2012

Management of myeloproliferative neoplasms: from academic guidelines to clinical practice.

Curr Hematol Malig Rep 2012 Mar;7(1):50-6

Unit of Clinical Epidemiology and Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Viale Golgi 19, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-011-0109-7DOI Listing
March 2012

Therapeutic approaches in myelofibrosis.

Expert Opin Pharmacother 2011 Jul 4;12(10):1597-611. Epub 2011 Apr 4.

IRCCS Policlinico S. Matteo Foundation, Unit of Clinical Epidemiology and Center for the Study of Myelofibrosis, Viale Golgi 19, 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2011.568939DOI Listing
July 2011

Bone marrow fibrosis in myeloproliferative neoplasms-associated myelofibrosis: deconstructing a myth?

Leuk Res 2011 May 5;35(5):563-5. Epub 2011 Feb 5.

Laboratory of Clinical Epidemiology and Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.01.013DOI Listing
May 2011

Evaluation of the bioactive and total transforming growth factor β1 levels in primary myelofibrosis.

Cytokine 2011 Jan 30;53(1):100-6. Epub 2010 Aug 30.

Laboratory of Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2010.07.427DOI Listing
January 2011